Clinical Cancer Research Abstracts
Careers
Contact | Tell Us About Your Study
Oncology Expertise
Immunotherapy
Operational Expertise
Investigator Relationships
Site Training
Indications
Services
Oncology CRO Services
Study Design
Study Launch
Study Management
Medical Writing
B/DM
Study Rescue
Drug Development Consulting
Access to the U.S. Market
Bioequivalence Design
Experience
Trial Experience
Drug Therapies
Rescue Studies
About
Approach
History
Leadership
Partners
Therapeutic Areas
Oncology
Dental
Nephrology
Medical Device and Diagnostics
Neurology and CNS
News/Blog
Home
Oncology Expertise
Services
Experience
About
Therapeutic Areas
News/Blog
Abstracts
Careers
Contact
Speed to market
News
Thought leaders
Phase I
Contract research
Drug development
Phase I
Speed to market
Tips for Bringing Your First Oncology Drug into the Clinic in the United States
While cancer is a global health challenge, the…
Read Article
News
Regulatory Affairs
Speed to market
FDA Breakthrough Therapy Designation: A Pathway for Expedited Drug Development
On July 9, 2012 the Food and Drug…
Read Article
Drug development
Phase I
Phase II
Speed to market
Thought leaders
“Context of vulnerability” and its role in targeted drug development
Renowned cancer researcher Dr. Daniel Von Hoff and…
Read Article
Drug development
Preclinical studies
Speed to market
Oncology clinical research scientist recommends a nuanced preclinical study process to speed drug development
Medelis has just published the third issue of…
Read Article
Contract research
Phase I
Preclinical studies
Speed to market
Insight: Preventing a Preclinical Dead End
Oncology preclinical studies are commonly viewed as straightforward…
Read Article
Contract research
Phase I
Phase II
Speed to market
Thought leaders
Dan Von Hoff discusses “The Complete Phase Ib”
Medelis has published a free new downloadable abstract,…
Read Article
